Pu-erh Tea for Health & Longevity - Quick Reference Sheet

Pu-erh Tea for Health & Longevity

Created on 09/30/2026 – Quick Reference based on Evidence Review created using AI4L + evidence-mcp / Sonnet 5.5 – Audit

Pu-erh tea is a fermented dark tea from Yunnan, China, consumed brewed or as oral extract capsules for weight, cholesterol and blood sugar. Human evidence rests on a few small studies that disagree, with the most favorable results from trials linked to an extract manufacturer. Downsides, based on indirect evidence, are sleep disruption, reduced plant-based iron absorption and, with burning-hot tea, food-pipe cancer risk. (Full Review)

Protocol

Extract capsule protocol
333 mg three times daily before meals
For 12 weeks; another trial used 3 g/day of extract for 20 weeks
Brewed leaf protocol
8 g/day steeped in 200 mL boiling water
Registered trial: 8 g once or 4 g twice, steeped 60-90 seconds
Best time of day
No servings within about 9 hours of bedtime
Earlier-day intake limits caffeine sleep effects; extract trial dosed before meals
Time to effect
Separation from placebo
From week 8
Seen in a Japanese extract trial
Cholesterol change
From week 4
Fell within the extract group; overall effect inconsistent and unconfirmed
Trial measurement window
12-20 weeks
Outcomes measured at 4-week intervals in trials

Benefits

Contraindications
  • Pregnant people with total caffeine at or above 200 mg/day
  • Breastfeeding mothers with high caffeine intake
  • Uncontrolled blood pressure of 180/120 mmHg or higher, or symptomatic arrhythmia (irregular heartbeat)
  • Ferritin below 30 ng/mL (iron deficiency) when tea accompanies meals
  • Known allergy to Camellia sinensis, caffeine or theabrownin
  • Total fluoride intake above 10 mg/day or established skeletal fluorosis
  • Severe immunocompromise (weakened immune system), as a precaution with aged or damp-stored products
Key Interactions
  • Caffeine-clearance inhibitors (fluvoxamine, ciprofloxacin, cimetidine, fluconazole)
  • Theophylline (asthma drug)
  • Stimulant medications (amphetamine, methylphenidate)
  • Lithium
  • Beta-blockers (atenolol; blood pressure and heart rate medicines)
  • Levodopa (Parkinson disease drug)
  • Diabetes and blood pressure medicines (metformin, insulin, amlodipine)
  • Warfarin
  • Caffeine-containing analgesic (pain reliever) and cold products (acetaminophen-caffeine, aspirin-caffeine, pseudoephedrine)
  • Oral iron (ferrous sulfate, ferrous fumarate)
  • Other caffeine sources (green tea extract, guarana, yerba mate, pre-workout products)
  • Glucose-, lipid- or pressure-lowering supplements (berberine, red yeast rice, psyllium)
  • Alcohol and smoking (burning-hot tea)

Risk & Side Effects

  • Low: Caffeine-Related Sleep Disruption and Stimulant Effects, Reduced Plant-Based Iron Absorption, Esophageal Cancer With Very Hot Tea, Fluoride Exposure and Fluorosis
  • Speculative: Mold Toxin and Metal Contaminant Exposure, Allergic Reactions

Monitoring

Marker Target Why
LDL-C <100 mg/dL (<2.6 mmol/L) Main lipid target in trials
ApoB <80 mg/dL Counts artery-clogging particles
Triglycerides <100 mg/dL Only lipid with a trend in one trial
HDL-C >50 mg/dL (men), >60 mg/dL (women) Protective lipid fraction
Fasting glucose 75-90 mg/dL Trial outcome with mixed results
HbA1c <5.3% 3-month average blood sugar
Blood pressure <120/80 mmHg Caffeine effect; trial outcome
Waist circumference <94 cm (men), <80 cm (women) Tracks abdominal fat
Ferritin 50-100 ng/mL Tracks tea's effect on iron stores
ALT <25 U/L Liver safety check used in trials
hs-CRP <1.0 mg/L Inflammation marker reported changed in one trial
Urinary fluoride No established target; track change from own baseline Gauges fluoride exposure with very high intake

Cadence: Baseline, 4 weeks, 12 weeks, then every 6-12 months; ferritin and liver enzymes at 12 weeks and then annually; urinary fluoride only with very high intake

Qualitative Assessment

  • Sleep quality (time to fall asleep, night awakenings)
  • Daytime energy and jitteriness
  • Digestive comfort and appetite
  • Palpitations or resting heart rate
  • Mood and anxiety